Filing Details

Accession Number:
0001622627-25-000005
Form Type:
13G Filing
Publication Date:
2025-02-06 19:00:00
Filed By:
Rosalind Advisors, Inc.
Company:
Optinose Inc. (NASDAQ:OPTN)
Filing Date:
2025-02-07
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Rosalind Advisors, Inc. 0 964,587 8.7%
SALAMON STEVEN A J 0 964,587 8.7%
Aharon Gil 0 964,587 8.7%
Rosalind Master Fund L.P. 0 964,587 8.7%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 10,055,300 shares of the Issuers common stock outstanding as of December 30, 2024 in accordance with Issuers 8K filed on December 30, 2024. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 876,996 shares of Common Stock 87,591 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Comment for Type of Reporting Person:  876,996 shares of Common Stock 87,591 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Comment for Type of Reporting Person:  (6) 876,996 shares of Common Stock 87,591 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Comment for Type of Reporting Person:  (6) 876,996 shares of Common Stock 87,591 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G


 
Rosalind Advisors, Inc.
 
Signature:Steven Salamon
Name/Title:President
Date:02/07/2025
 
SALAMON STEVEN A J
 
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:02/07/2025
 
Aharon Gil
 
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:02/07/2025
 
Rosalind Master Fund L.P.
 
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:02/07/2025